Divisadero Street Capital Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-38,390
Closed -$4.31M 175
2025
Q3
$4.31M Hold
38,390
0.19% 80
2025
Q2
$5.14M Sell
38,390
-75,481
-66% -$8.29M 0.33% 54
2025
Q1
$7.66M Sell
113,871
-44,609
-28% -$3.07M 0.77% 35
2024
Q4
$9.88M Buy
158,480
+120,090
+313% +$11.2M 1.15% 26
2024
Q3
$6.03M Buy
38,390
+5,161
+16% +$795K 0.73% 30
2024
Q2
$5M Sell
33,229
-42,707
-56% -$5.12M 0.76% 35
2024
Q1
$5.61M Buy
75,936
+17,866
+31% +$1.47M 1.31% 21
2023
Q4
$4.58M Hold
58,070
1.04% 27
2023
Q3
$3.18M Sell
58,070
-266,930
-82% -$19.2M 1% 28
2023
Q2
$27.3M Buy
325,000
+265,000
+442% +$20.3M 7.89% 1
2023
Q1
$4.54M Buy
60,000
+22,000
+58% +$1.52M 1.99% 18
2022
Q4
$2.35M Sell
38,000
-82,000
-68% -$4.36M 1.75% 20
2022
Q3
$5.01M Buy
+120,000
New +$5.22M 5.56% 1
2022
Q2
Sell
-12,000
Closed -$323K 55
2022
Q1
$323K Buy
+12,000
New +$215K 0.27% 36

Other funds holding TMDX

Divisadero Street Capital Management's TMDX Position: Q4 2025 in Review

Divisadero Street Capital Management sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 38,390 shares — an estimated $4.31M sold.

Divisadero Street Capital Management first reported a position in TMDX in Q1 2022 and held it in 14 quarters. The position peaked at $27.3M in Q2 2023. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Divisadero Street Capital Management reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Divisadero Street Capital Management sold 38,390 Transmedics shares in Q4 2025, an estimated $4.31M.
  • Divisadero Street Capital Management first reported a position in Transmedics in Q1 2022 and held it in 14 quarters.
  • Divisadero Street Capital Management's Transmedics position peaked at $27.3M in Q2 2023.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Divisadero Street Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.